UCSF Professor Aditi Bhargava brought up the issue with N-antibodies in November of 2021. People have been too quick to dismiss her concern.
In its Week 42 “COVID-19 Vaccine Surveillance Report” (published 21 October 2021), the UK Department of Health admits on page 23 that “recent observations from UK Health Security Agency (UKHSA) surveillance data that N antibody levels appear to be lower in individuals who acquire infection following 2 doses of vaccination.”
What does this mean? It means that the vaccine interferes with the body’s ability to make antibodies after infection against other parts of the virus.
Continue reading “The story of N-antibodies and why they are so important”
